DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
DataBase of pulmoNary hyPertesion in PoLish Population - BNP-PL
The BNP-PL is a multicenter, observational study in which patients are prospectively followed
 in order to investigate clinical course and management of pulmonary hypertension in Poland.

 All patients diagnosed with pulmonary arterial hypertension and chronic thromboembolic
 pulmonary hypertension confirmed in right heart catheterization, will be eligible to
 participate in the study.
The BNP-PL Registry is an initiative of the Polish Cardiac Society Task Force for Pulmonary
 Vascular Diseases This study is conducted by the Polish Cardiac Society. All centers of
 pulmonary hypertension in Poland which are accredited by the National Health Fund have been
 invited to join the study. The data is administrated by the Jagiellonian University Medical
 College on the basis of an agreement between the Polish Cardiac Society, Jagiellonian
 University Medical College and pulmonary hypertension centres.

 The goal is to describe current practice and outcomes in patients with pulmonary arterial
 hypertension and chronic thromboembolic pulmonary hypertension.

 The data collection will have no impact on the way the patient is diagnosed and treated.

 Collection of data on patients with pulmonary hypertension is carried out via the electronic
 platform.

 No personal data is entered into the project database.
Inclusion Criteria:

 Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary
 hypertension diagnosed after 1st March 2018 (incident cases) who:

 -  are aged > 3 months at the time of enrollment

 -  fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of
 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular
 end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance
 (PVR) of 3 Woods.

 Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary
 hypertension diagnosed before 1st March 2018 (prevalent cases) who:

 -  are aged > 3 months at the time of enrollment

 -  fulfill the following hemodinamic criteria: mean pulmonary arterial pressure (mPAP) of
 25 mm Hg or more, mean pulmonary arterial wedge pressure (PAWP) or left ventricular
 end-diastolic pressure (PVEDP) of 15 mm Hg or less, pulmonary vascular resistance
 (PVR) of 3 Woods